As the pandemic unfolds, clinical research continues to progress. How has the field of clinical research changed as a result of the crisis? Join Darshan Kulkarni as he talks with the CEO of Affinity Bio Partners Christina DiArcangelo about how patients have been impacted by the disease, and whether clinical research has been stalled. We’ll also talk about how the clinical research space has had to adapt in the face of the global pandemic.
Pharmaceutical companies have spent billions of dollars in an effort to create COVID-19 vaccines and drugs. Should the federal government...
Due to Brexit, the distribution of the COVID-19 vaccine has been affected. Has Brexit slowed Britain’s COVID vaccine program? Join Darshan...
Want to stay informed about updates on COVID-19 from qualified academics? Join Darshan Kulkarni as he discusses who he follows on social...
